Ad Astra Rocket Company

What it is

Ad Astra Rocket Company is a U.S. Delaware corporation dedicated to the development of advanced plasma rocket propulsion technology. It works on the Variable Specific Impulse Magnetoplasma Rocket — VASIMR® — and on hydrogen transport systems.

VASIMR is intended to achieve several advantages over chemical rocket designs, including lunar cargo transport, in-space refueling, and ultra-high speeds for distant space missions. Through subsidiaries in the US and Costa Rica, the company also develops earthbound applications in renewable energy, green hydrogen, advanced manufacturing, and applied physics.

It is authorised by Costa Rica’s securities regulator, SUGEVAL, to conduct restricted public offerings of its common stock, conducted under Costa Rican law outside the United States. This is an unusual structure: a US-incorporated, Texas-based lab that raises retail capital from Costa Rican investors through the BNV.

Who owns it

On July 8, 2005, after 25 years of government service, Dr. Franklin Chang Díaz retired from NASA to continue his work on VASIMR, becoming the founder and Chairman and CEO of Ad Astra Rocket Company. He is the dominant individual stakeholder, though the precise ownership percentage is not disclosed in available sources.

The capital structure is multi-layered: the company’s certificate of incorporation authorises 100,000 shares of preferred stock, issued across Series A, C, D, E, and F classes. In the first half of 2025 the company raised $8 million through a new preferred stock issuance, transforming a working-capital deficit of $3.1 million at year-end 2024 into a positive $5.2 million by June 2025.

Who runs it

Dr. Franklin Chang Díaz is Chairman and CEO — a Costa Rican-American scientist with a PhD in applied plasma physics from MIT, running a firm with operations in Webster, Texas and Guanacaste, Costa Rica. He has logged over 1,600 hours in space across seven NASA missions.

The board appointed James C. Clarke as Chief Financial Officer, effective April 1, 2022.

Menara Mora serves as President of the Board of Directors.

The money, in plain words

As a company in its development phase, Ad Astra has historically focused on strategic research and development, which has led to a period of net losses and negative cash flows from operations. In plain terms: it is not yet a commercial business — it is an advanced research programme financed by investors.

For the year ended December 31, 2024, the company recorded research, design and development income of $849,231 (₡382.3 million at current rates), related to hydrogen transport systems and complementary technologies. Against that, it spent $2,221,883 on operations — a net loss of $1,456,088 (-₡655.4 million), a net margin of -171.5% (our calculation), meaning it spent $2.71 for every $1 it earned.

At December 31, 2024, total assets stood at $2,160,348 (₡972.5 million) against liabilities of $5,468,279 (₡2.46 billion), leaving a stockholders’ deficit — meaning owners’ equity is negative — of -$3,307,931 (-₡1.49 billion). The independent auditor’s report for FY2024 carried a formal going-concern warning, meaning the auditors flagged genuine doubt about the company’s ability to keep operating without fresh funding.

The picture shifted sharply in early 2025: as of June 30, 2025, the company reported positive working capital of $5,182,235, after raising $8 million in new preferred equity — a decisive improvement, though the accumulated deficit now stands at $48.1 million.

What it is doing now

In August 2024, NASA delivered $10 million in funding to Ad Astra for further VASIMR development as part of its “Next Space Technologies for Exploration Partnership” programme. That award, larger than a full year of the company’s prior income, validated the engine concept at a critical moment.

In December 2024, Ad Astra and The Space Nuclear Power Corporation (SpaceNukes) signed a strategic partnership to advance high-power nuclear electric propulsion technology for human and robotic missions to Mars, combining VASIMR with SpaceNukes’ Kilopower reactor technology. SpaceNukes estimates a Mars round-trip could take only a few months; both companies aim for an orbital demonstration by the late 2020s and commercialisation in the 2030s.

What to watch

• Going-concern clock: the auditor’s warning will persist until the company can show recurring income covers operating costs; watch each quarterly filing for the cash burn rate.
• NASA milestone contracts: the VASIMR® rocket technology is not yet commercially viable for direct sale — each new NASA contract or grant is the primary revenue lifeline.
• Nuclear electric propulsion timeline: the Ad Astra–SpaceNukes partnership has set no specific development timeline; any firm government contract or test date would be a material catalyst.
• BNV liquidity & regulatory compliance: trading in Ad Astra’s shares was suspended on the BNV in April 2024 and only resumed on June 11, 2024 after the delayed audit was filed — a reminder that this is a thinly traded, regulatory-sensitive listing.
• Hydrogen subsidiary: the Costa Rica subsidiary in Liberia, Guanacaste develops distributed renewable energy and hydrogen energy systems; whether that arm can generate steady income before the rocket reaches orbit matters greatly.

This is news, not investment advice.